BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

13 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations.EBI
Kinnate Biopharma
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition.EBI
Kinnate Biopharma
COMPOUND FOR REGULATING AND CONTROLLING 15-PGDH ACTIVITY AND PREPARATION METHOD THEREFORBDB
Scinnohub Pharmaceutical
SUBSTITUTED PYRIDINES AS PARP1 INHIBITORSBDB
Xinthera
Glucagon-like peptide1 receptor agonistsBDB
Eli Lilly
Anti-inflammatory compound, and preparation and use thereofBDB
E-Nitiate Biopharmaceuticals (Hangzhou)
Dihydroquinolinones for medical treatmentBDB
C4 Therapeutics
Inhibitors of RAF kinasesBDB
Kinnate Biopharma
RIP1 inhibitory compounds and methods for making and using the sameBDB
Rigel Pharmaceuticals
Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitorsBDB
Bayer Aktiengesellschaft
Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsBDB
Janssen Pharmaceutica
Thiazole derivative and applicationsBDB
East China University of Science and Technology
Dihydroxybenzamide compound having HSP90 inhibitory activity or pharmaceutically acceptable salt thereof, and medical use thereofBDB
Oncozen